NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN)

26 filings reported holding NKGN - NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
NKGen Biotech, Inc. - Common Stock, $0.0001 par value per share (NKGN) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7,585,892 shares of 133,846,019 outstanding shares and own 5.7% of the company stock.
Largest 10 shareholders include Pathstone Holdings, LLC (2,797,661 shares), METEORA CAPITAL, LLC (2,772,145 shares), UNIVERSITY OF CHICAGO (550,000 shares), Diametric Capital, LP (518,134 shares), Kepos Capital LP (230,022 shares), VANGUARD GROUP INC (227,804 shares), Sequoia Financial Advisors, LLC (156,000 shares), GEODE CAPITAL MANAGEMENT, LLC (127,168 shares), ADVISORY RESEARCH INC (43,088 shares), and XTX Topco Ltd (33,625 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.